Tony J Kenna Selected Research

Proteoglycans (Proteoglycan)

1/2017	Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis.
1/2016	Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tony J Kenna Research Topics

Disease

12	Ankylosing Spondylitis 01/2020 - 07/2011
5	Inflammation (Inflammations) 01/2018 - 12/2012
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 10/2016
3	Neoplasms (Cancer) 01/2022 - 06/2010
3	Arthritis (Polyarthritis) 01/2020 - 01/2013
2	Disease Progression 01/2017 - 01/2016
2	Spondylitis 01/2017 - 01/2016
2	Joint Diseases (Joint Disease) 06/2014 - 01/2013
1	Systemic Scleroderma (Systemic Sclerosis) 02/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2024
1	Uveitis 01/2023
1	Reactive Arthritis (Reiter Disease) 01/2020
1	Spondylarthropathies 01/2020
1	Birdshot Chorioretinopathy 05/2019
1	Immune System Diseases (Immune Disorders) 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2016
1	Weill-Marchesani Syndrome 01/2016
1	Necrosis 11/2015
1	Disease Susceptibility (Diathesis) 07/2011
1	Anauxetic dysplasia 03/2011
1	Autoimmune Diseases (Autoimmune Disease) 01/2010

Drug/Important Bio-Agent (IBA)

7	AminopeptidasesIBA 01/2023 - 07/2011
3	HLA-B Antigens (HLA-B)IBA 01/2020 - 07/2013
2	AntigensIBA 01/2020 - 06/2010
2	EnzymesIBA 05/2019 - 01/2013
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2018 - 07/2011
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
2	CytokinesIBA 01/2017 - 01/2013
2	Proteoglycans (Proteoglycan)IBA 01/2017 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 11/2015 - 01/2013
2	Peptides (Polypeptides)IBA 07/2013 - 07/2011
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	Histocompatibility Antigens Class IIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	LigandsIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	Fibrillin-1IBA 01/2016
1	Endoplasmic Reticulum Chaperone BiPIBA 11/2015
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 06/2014
1	Interleukin-1 (Interleukin 1)IBA 01/2013
1	Interleukin-17 (Interleukin 17)IBA 01/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	Toll-Like Receptor 7IBA 12/2012
1	Imiquimod (Aldara)FDA LinkGeneric 12/2012
1	Interleukin-2 (IL2)IBA 12/2012
1	Interleukin-23 (Interleukin 23)IBA 05/2012
1	RNA (Ribonucleic Acid)IBA 03/2011
1	mitochondrial RNA-processing endoribonuclease (RNAse MRP)IBA 03/2011
1	Ribonucleases (Ribonuclease)IBA 03/2011
1	Mitochondrial RNAIBA 03/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2010
1	Viral AntigensIBA 06/2010

Therapy/Procedure

4	Immunotherapy 01/2022 - 01/2010
4	Therapeutics 01/2018 - 12/2012